Seminars in Oncology Nursing最新文献

{"title":"Young Adult Siblings and Cancer: A Scoping Review Mapping the Evidence of Psychosocial Functions and Interventions","authors":"Helene Vasegaard ,&nbsp;Anne Møller Clausen ,&nbsp;Maiken Langhoff Kidholm ,&nbsp;Elisabeth Coyne ,&nbsp;Karin Brochstedt Dieperink","doi":"10.1016/j.soncn.2025.151834","DOIUrl":"10.1016/j.soncn.2025.151834","url":null,"abstract":"<div><h3>Objectives</h3><div>To investigate the evidence concerning the psychosocial functions among young adults (18-29 years) with a sibling diagnosed with cancer and the psychosocial interventions developed for this group.</div></div><div><h3>Methods</h3><div>Utilising the Joanna Briggs Institute's guidelines for scoping reviews, a comprehensive search across five databases, including PubMed, Scopus, CINAHL, PsycInfo, and the Cochrane Library, was conducted. A chain search and a search for grey literature in Google Scholar complemented the search.</div></div><div><h3>Results</h3><div>A total of 1937 titles and abstracts were screened, with 250 full-text articles read for inclusion. Seven studies met the inclusion criteria consisting of qualitative (n = 2), quantitative (n = 3), and mixed method (n = 2). Two of these described interventions; a family-centred intervention and a person-centred intervention specifically targeted at siblings. Through data analysis of the results from the seven studies, three themes emerged: (1) the sibling's inner struggle: coping strategies, emotional suppression, and ambivalent feelings; (2) informed understanding: the vital role of communication; and (3) seeking support: addressing social estrangement and strengthening familial bonds.</div></div><div><h3>Conclusion</h3><div>This scoping review highlights the profound emotional and psychosocial difficulties faced by young adult siblings when a sibling's cancer affects family dynamics. It summarizes findings from studies employing qualitative, quantitative, and mixed-methods methodologies. The interventions used were successful; however, the limited number of these interventions emphasizes the need for further research. This research is essential to develop strong support networks and communication strategies to help young adults aged 18 to 29 manage their complex emotional responses and family roles effectively.</div></div><div><h3>Implication for Nursing Practice</h3><div>To support young adults with a sibling diagnosed with cancer, a family-centered approach is essential for assessing their individual support needs. Developing interventions targeting young adult siblings and enhancing family communication may benefit both the siblings and the family as a whole.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151834"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143400776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Role of Prehabilitation in Oncology Patients Undergoing Complex Systemic Anticancer Therapy","authors":"Tessa Renouf","doi":"10.1016/j.soncn.2025.151812","DOIUrl":"10.1016/j.soncn.2025.151812","url":null,"abstract":"<div><h3>Objectives</h3><div>To review the recent literature around the role of patient-centric prehabilitation for oncology patients undergoing complex systemic anticancer therapy (SACT) and the nurse's role in this area.</div></div><div><h3>Method</h3><div>A narrative review of recent peer-reviewed literature, national guidance, and government strategy for prehabilitation in oncology patients undergoing complex SACT.</div></div><div><h3>Results/Conclusion</h3><div>Prehabilitation interventions in people receiving complex SACT are feasible and benefit patient outcomes. These results must still be viewed with caution; however, as of now, there are only small-scale studies in this area, although larger-scale studies are now being done. The role of the nurse is key here (as part of the interdisciplinary team) through the establishment of the therapeutic relationship underpinning patient screening, assessment, intervention implementation, and patient reassessment, ensuring care is dynamic, consistent, and tailored to patient needs.</div></div><div><h3>Implications for Nursing Practice</h3><div>The review has discussed the beneficial patient outcomes from prehabilitation in patients receiving complex SACT, but more research is warranted in the form of larger multisite trials to increase the validity of the prehabilitation interventions. The review advocates for the role of the nurse in the provision of prehabilitation in SACT oncology patients through the provision of personalized patient care.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151812"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143411505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Shift in Practice: A Discussion of the Impact of Immunotherapy on Cancer Nursing","authors":"Joanne Bird ,&nbsp;Mary Anne Tanay ,&nbsp;Nalayini “Nellie” Kumaralingam","doi":"10.1016/j.soncn.2025.151819","DOIUrl":"10.1016/j.soncn.2025.151819","url":null,"abstract":"<div><h3>Objective</h3><div>This paper aims to explore the impact of checkpoint inhibitors, a novel cancer therapy, on cancer nursing, including aspects of education, research, and practical application.</div></div><div><h3>Methods</h3><div>Our discussion is grounded in clinical expertise and supported by relevant literature from peer-reviewed journals.</div></div><div><h3>Results</h3><div>This focused discussion on the nursing implications of immune checkpoint inhibitors as a novel cancer therapy highlights a significant transformation in cancer nursing practice. There is a pressing need to enhance the skills of the cancer nursing workforce and expand their knowledge regarding the mechanisms of action of immunotherapies, their toxicity profiles, including late effects, potential drug interactions, principles of administration, and the assessment and management of immune-related adverse reactions. The introduction of immunotherapy necessitates not only a collaborative multidisciplinary approach but also a multispecialty strategy due to the diverse nature of immune-related side effects affecting various body systems. The complexity of managing toxicities associated with immunotherapy, particularly when used in conjunction with other treatment modalities, imposes additional costs and strains on existing healthcare services. Some organizations, depending on their healthcare models, encounter challenges when these additional services are not appropriately funded.</div></div><div><h3>Conclusion</h3><div>In the case of immunotherapy as a novel cancer treatment, there are clear benefits to patients in terms of survival, but this has come with safety issues for patients and staff. The nursing workforce is key to safety around immunotherapy with regard to the safe delivery of treatment and the management of toxicity. This cannot be achieved without the education of the nursing workforce and underpinning research.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151819"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143434397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to “A Biofeedback Based Virtual Reality Game for Pediatric Population (BioVirtualPed): A Feasibility Trial” Seminars in Oncology Nursing 40(2024) 151615","authors":"Eyşan Hanzade Savaş ,&nbsp;Remziye Semerci ,&nbsp;Ata Sayın ,&nbsp;Betül Dinçer ,&nbsp;Beren Semiz ,&nbsp;Hakan Ürey","doi":"10.1016/j.soncn.2025.151818","DOIUrl":"10.1016/j.soncn.2025.151818","url":null,"abstract":"","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151818"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143061470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predictor Factors Associated With Hazardous Drug Safe Handling Precautions Across a UK Oncology Nurse Sample and Implications for Novel Treatments","authors":"Karen Campbell ,&nbsp;Daniel Dicksit ,&nbsp;Martha Polovich","doi":"10.1016/j.soncn.2025.151817","DOIUrl":"10.1016/j.soncn.2025.151817","url":null,"abstract":"<div><h3>Objectives</h3><div>The development and use of novel systemic anticancer therapy (SACT) treatments are advancing rapidly. While cytotoxic drugs have traditionally been the cornerstone of treatment, they are increasingly used alongside novel agents. This study aims to assess factors affecting adherence to safe-handling precautions, enhance safety protocols, and minimize potential occupational exposure to hazards in clinical environments, increasing their capacity for novel treatments.</div></div><div><h3>Methods</h3><div>Cross-sectional, online survey of oncology nurses across the UK who handled SACT. Participants were asked to complete the <em>Factors Predicting Use of Hazardous Drug Safe-Handling Precautions</em> Questionnaire. Descriptive analysis, Spearman rank correlation coefficients, and regression analysis were performed to determine the predictors of precautionary use when handling HDs.</div></div><div><h3>Findings</h3><div>Analysis of (n = 675) participants revealed high knowledge of exposure, high self-efficacy, low perceived barriers, moderate perceived risks, high interpersonal influence, low conflict of interest and moderate safety climate in the workplace. The analysis of the data also indicated weak positive correlations between age and knowledge (rs = 0.093), self-efficacy (rs = 0.103) and safe-handling scores (rs = 0.082); the age of the participants has a weak negative correlation to perceived barriers (rs = –0.141), conflict of interest (rs = –0.116), and workplace safety climate(rs = –0.116). Notably, safe handling scores showed no significant correlation with other theoretical predictors. Comparison between government and private sector nurses (n = 76) demonstrated higher patient volumes F (15.807, 74), <em>P</em> &lt; .001 and significantly lower safe handling scores in the government settings F (4.135, 74) <em>P</em> &lt; .05.</div></div><div><h3>Conclusions</h3><div>Nurse-patient ratios between government and private sector settings predict global safe-handling precautions.</div></div><div><h3>Implications for practice</h3><div>Novel treatments for nurse-patient ratios are essential, as new therapies and schedules further create additional workload pressures that may reduce safe handling practices.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151817"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143532110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Immersive Virtual Reality Experience of Patients with Cancer During Intravenous Antiblastic Therapy: A Qualitative Study","authors":"Francesco Burrai ,&nbsp;Maria Matarese ,&nbsp;Valentina Micheluzzi ,&nbsp;Giulia Cadeddu ,&nbsp;Maria Grazia De Marinis ,&nbsp;Michela Piredda","doi":"10.1016/j.soncn.2025.151813","DOIUrl":"10.1016/j.soncn.2025.151813","url":null,"abstract":"<div><h3>Objectives</h3><div>To explore the experiences patients with cancer using immersive virtual reality (iVR) during antineoplastic infusion therapy.</div></div><div><h3>Methods</h3><div>A qualitative descriptive study was nested in a randomized controlled three-arm trial. Semistructured individual interviews were conducted in person at the end of the 30-minute iVR experience, which included 310 scenarios, depicting beaches, animals, submarine environments, and mountains, available in 4K to 8K 360° sphere video. The interviews were audio-recorded and transcribed verbatim. The transcripts were analyzed using content analysis.</div></div><div><h3>Results</h3><div>Twenty-four patients participated. Content analysis generated three main categories (cognitive and emotional benefits of iVR, customizable intervention with beautiful images, and negative aspects of iVR), and seven subcategories (enrichment of knowledge and experiences, positive emotions, cognitive engagement, variety of scenarios, quality and beauty of the videos, discomfort with the equipment, negative feelings toward the iVR devices).</div></div><div><h3>Conclusions</h3><div>The patients’ experience with iVR was positive and enhanced their experience of receiving antineoplastic infusion therapy, with minimal cybersickness.</div></div><div><h3>Implications for Nursing Practice</h3><div>iVR is an innovative intervention that can be implemented in nursing practice to enhance the humanization of care and foster a patient-centered approach in patients undergoing antineoplastic infusion therapy.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151813"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effectiveness of Technology-Based Intervention in Symptom Management in Pediatric Oncology Patients: A Systematic Review and Meta-Analysis","authors":"Eyşan Hanzade Savaş ,&nbsp;Aylin Akça Sümengen ,&nbsp;Remziye Semerci","doi":"10.1016/j.soncn.2025.151808","DOIUrl":"10.1016/j.soncn.2025.151808","url":null,"abstract":"<div><h3>Background</h3><div>Technology-based interventions are increasingly integrated to improve symptom management of pediatric oncology patients. However, evidence for their effectiveness remains low across various studies characterized by different methodologies and patient populations. This study aimed to synthesize and analyze the effectiveness of technology-based intervention in symptom management in pediatric oncology patients.</div></div><div><h3>Methods</h3><div>Six databases (PubMed, Web of Science, Cochrane Library, Ovid MEDLINE, CINAHL, and Scopus) were searched from January 1, 2014, to January 1, 2024. The methodological quality of the included studies was assessed using the Cochrane and JBI checklists. The PRISMA guidelines for systematic reporting were followed in this study. The search protocol has been registered with the PROSPERO International Prospective Register of Systematic Reviews (CRD42024516320).</div></div><div><h3>Results</h3><div>Thirteen studies with 624 pediatric oncology patients were analyzed. Significant differences were found between intervention and control groups in pain (Hedge's g = −0.695, 95% CI: −0.994 to −0.396, p &lt; 0.001), fear (Hedge's g = −0.737, 95% CI: −1.01 to −0.464, p &lt; 0.001), anxiety, and nausea and vomiting (Hedge's g = −0.573, 95% CI: −0.912 to −0.235, p &lt; 0.001).</div></div><div><h3>Conclusion</h3><div>The findings indicate that VR, iPad, humanoid robots, and Pain Squad reduce pain in pediatric oncology. VR, biofeedback-based VR, and iPads also alleviate fear, while all three plus humanoid robots mitigate anxiety. VR, interactive mobile apps, tablet games, text reminders, and iPads effectively decrease nausea and vomiting. More research is needed to evaluate the long-term effects of these interventions.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151808"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What Is the Impact of Novel Systemic Anticancer Therapy on Acute Oncology Education and Service Delivery?","authors":"Gina Madera ,&nbsp;Ali Hodge ,&nbsp;Lara Roskelly ,&nbsp;Clare Greenbaum","doi":"10.1016/j.soncn.2025.151842","DOIUrl":"10.1016/j.soncn.2025.151842","url":null,"abstract":"<div><h3>Objectives</h3><div>To discuss the importance of educating healthcare professionals about oncological emergencies linked to novel systemic anticancer therapy (SACT) and the impact on acute oncology (AO) services.</div></div><div><h3>Methods</h3><div>This discussion is based on clinical expertise and informed by current literature.</div></div><div><h3>Results</h3><div>Novel SACT, such as immune-checkpoint inhibitors, have more complex toxicity profiles and can be challenging to recognize and treat. An increasing prevalence of toxicity is expected as new drugs are developed and the numbers of patients living with and beyond cancer expand; more data are required to capture the full extent of this.</div><div>There are knowledge gaps within the healthcare workforce, particularly outside oncology-specialist settings. Focused research in this area will provide direction for targeted educational interventions.</div></div><div><h3>Conclusions</h3><div>Insufficient SACT education is a safety issue; severe toxicities can be fatal but initial symptoms can be subtle and may be missed. We argue that emergency care pathways can help to streamline the appropriate management of patients with SACT toxicity, but awareness of AO issues remains “everyone's business.”</div><div>Continuing clinical education is key to maintaining awareness of newly developed SACT. AO service models may vary, but AO competence assessment passports can provide a standardized method of evidencing AO knowledge and skills.</div></div><div><h3>Implications for Nursing Practice</h3><div>Oncology nurses, as a highly specialized and knowledgeable part of the healthcare workforce, are key in supporting interprofessional education. By using existing cancer nursing frameworks, this can support the implementation of the AO Passports. The learning and development of AO services in the UK can be transferred internationally.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151842"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143477255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Plasma IL-1β Concentration Associates with Sleep Quality and Cognitive Functions in Men with Prostate Cancer","authors":"Mayra Alejandra Mafla-España RN, PhD ,&nbsp;Elsa Vitale RN, PhD ,&nbsp;María Dolores Torregrosa MD, PhD ,&nbsp;Omar Cauli MD, PhD","doi":"10.1016/j.soncn.2025.151845","DOIUrl":"10.1016/j.soncn.2025.151845","url":null,"abstract":"<div><h3>Objectives</h3><div>The purpose of this study was to ascertain whether sleep quality is altered in patients with prostate cancer (PCa) during androgen deprivation therapy (ADT) and whether sleep impairment associates with depressive symptoms, cognitive function or frailty syndrome, and if this varies between patients with localized or metastatic disease. The pro-inflammatory cytokine, IL-1β is involved in sleep regulation, we assessed whether sleep quality, depressive symptoms, cognitive function or frailty syndrome are associated with IL-1β concentration.</div></div><div><h3>Methods</h3><div>Sleep quality was assessed using the Athens Insomnia Scale (AIS), depressive symptoms using the Yesavage Scale (GDS), and cognitive functions using the MiniMental State Exam (MMSE) and the level of frailty was measured based on the Fried criteria. Plasma IL-1β was measured by enzyme-linked immunoassay. Linear regression lanalyses were performed to determine which variables predict plasma IL-1β is involved in poor sleep quality and higher IL-1β concentration.</div></div><div><h3>Results</h3><div>A cross-sectional study was carried out between 2021 and 2023. Sixty-seven men with PCa (N=36 (53.7%) with localized disease and N=31 (46.3%) with metastatic disease) were enrolled in the study. Plasma IL-1β concentration correlated with poorer sleep quality in all sample and, men with metastatic PCa had poorer sleep quality compared to men with localized disease. Analysis of self-reported sleep quality revealed that half of them had insomnia symptoms and 19.4% reported clinically relevant insomnia disorder (mean value of AIS 3.39±0.44). Poor sleep quality significantly predicted the concentration of IL-1β in plasma. In contrast, a better cognitive function significantly (<em>P</em> = .037) predicted IL-1β concentration. Detailed analysis of AIS items showed that score in the item “Sleep induction” and “Sleepiness during the da) significantly predicted IL-1β concentrations (<em>P</em> = .001 and P0=.044, respectively).</div></div><div><h3>Conclusions</h3><div>Plasma IL-1β levels may be useful to address the presence of insomnia in patients with PCa who are receiving ADT and to monitor the effect of interventions to improve sleep problems in these patients.</div></div><div><h3>Implications for Nursing Practice</h3><div>Nurses will play a critical role in educating patients about their risk for specific symptoms based on an evaluation of specific biomarkers such as IL-1β and sleep quality. Nurses will be involved in using biomarker data to titrate medications and to evaluate the effect of nonpharmacological interventions to improve sleep quality in patients with PCa.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151845"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143517427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Understanding Nurses' Role in Systemic Anti-cancer Therapy Day Unit: A Qualitative Study","authors":"Zhuming Bao ,&nbsp;Jenny Harris ,&nbsp;Verna Lavender ,&nbsp;Anne Marie Rafferty ,&nbsp;Jo Armes","doi":"10.1016/j.soncn.2024.151720","DOIUrl":"10.1016/j.soncn.2024.151720","url":null,"abstract":"<div><h3>Objectives</h3><div>Internationally systemic anti-cancer therapy (SACT) nurses are facing increasing workload challenges against the backdrop of rising patient numbers, innovations in systemic anti-cancer therapies and continued development of responsive outpatient chemotherapy systems. This raises concerns about the possible effects on the quality of patient care and has implications for workforce outcomes (e.g., wellbeing, staff retention). This study aims to explore in-depth aspects of SACT day unit nurses' work including their roles and responsibilities (e.g., safe chemotherapy administration, symptom assessment, information giving, self-management advice, and psychosocial support).</div></div><div><h3>Methods</h3><div>Qualitative, online, semi-structured interviews with SACT nurses which analysed using thematic analysis.</div></div><div><h3>Results</h3><div>15 SACT day unit nurses were recruited. Two key themes emerged from the analysis: ‘SACT day unit nurses' roles’ and ‘Factors affecting SACT day unit nurses' roles’. The theme ‘SACT day unit nurses' roles’ encompassed four distinct sub-themes: the specialist clinical role, informal leadership role, enabling work role and supportive role. The theme ‘Factors affecting SACT day unit nurses’ encompassed workforce shortages, work overload, treatment delays, and lack of recognition and support.</div></div><div><h3>Conclusions</h3><div>The themes provided insights into the responsibilities and challenges that impact SACT day unit nurses in fulfilling their roles effectively. By detailing the care provided within the SACT day units, this study addresses the current research gap pertaining to the roles of SACT day unit nurses.</div></div><div><h3>Implications for Nursing Practice</h3><div>The multifaceted roles of SACT day unit nurses encompasses clinical expertise, leadership capabilities, facilitative roles, and supportive functions within the cancer care pathway. Understanding these roles and the challenges nurses face, such as workforce shortages and treatment delays, is crucial for optimizing patient care and addressing the well-being and retention of nursing staff in this specialized field.</div></div>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":"41 2","pages":"Article 151720"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}